SPARK THERAPEUTICS, INC. Proceeds from Issuance Initial Public Offering
SPARK THERAPEUTICS, INC. reported Proceeds from Issuance Initial Public Offering of $380.01 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-11-07
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2017-09-30 was $380.01M.
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2016-09-30 was -$115.54K.
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2016-06-30 was $127.68M.
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for the quarter ending 2016-03-31 was -$657.33K, a 100.39% decline year-over-year.
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for fiscal 2015 was $270.40M.
- SPARK THERAPEUTICS, INC. proceeds from issuance initial public offering for fiscal 2014 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 10 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|---|
| 2017-09-30 | $380.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $380.01M 10-Q · filed 2017-11-07 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | |||||
| 2016-09-30 | -$115.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $127.57M derived: sum of 2 quarters · filed 2017-11-07 | $126.91M 10-Q · filed 2017-11-07 | $227.00M derived: sum of 4 quarters · filed 2017-11-07 | ||
| 2016-06-30 | $127.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $127.02M 10-Q · filed 2017-08-02 | $227.11M derived: sum of 3 quarters · filed 2017-08-02 | $227.11M derived: sum of 4 quarters · filed 2017-08-02 | ||
| 2016-03-31 | -$657.33K 10-Q · filed 2016-05-06 | $99.43M derived: sum of 2 quarters · filed 2016-05-06 | $99.43M derived: sum of 3 quarters · filed 2016-11-04 | $99.27M derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-12-31 | $100.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $100.09M derived: sum of 2 quarters · filed 2016-11-04 | $99.93M derived: sum of 3 quarters · filed 2016-11-04 | $270.40M 10-K · filed 2016-03-14 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$157.41K derived: sum of 2 quarters · filed 2016-11-04 | $170.31M 10-Q · filed 2016-11-04 | $170.31M derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-06-30 | -$157.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $170.31M 10-Q · filed 2016-08-10 | $170.31M derived: sum of 3 quarters · filed 2016-08-10 | |||
| 2015-03-31 | $170.47M 10-Q · filed 2016-05-06 | $170.47M derived: sum of 2 quarters · filed 2016-05-06 | ||||
| 2015-02-04 | $185.20M 10-K · filed 2017-02-28 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 10-K · filed 2016-03-14 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-06 | |||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 |